A tribute to Dr. Mark Hallett, whose pioneering work in movement disorders reveals that awareness — not effort — is the true ...

Andrea Leeb was just four and a half years old when her mother, Marlene, saw something so shocking, it turned her world black. Diagnosed with ‘hysterical blindness’, it took four weeks and an extended ...

Trulieve Cannabis Corp. ( OTCQX:TCNNF) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Good morning, everyone, and welcome to the Trulieve Cannabis Corporation Third Quarter 2025 Financial Results ...

Arcutis Biotherapeutics announced strong third-quarter 2025 results, reporting revenue of $99.2 million and achieving profitability for the first time, which surpassed analyst expectations. Following ...

Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce a non-brokered private placement for gross ...

Planned U.S. launch of Anaphylm™ in the first quarter of 2026, if approved by the FDA Advanced Anaphylm regulatory activities in Canada and the ...

When University of Virginia neuroscientist Harald Sontheimer shared this year’s International Prize for Translational ...

Q3 2025 Earnings Call Transcript November 4, 2025 Harmony Biosciences Holdings, Inc. misses on earnings expectations.

Most newly diagnosed patients with epilepsy do gain lasting control of their seizures, even if their first medication doesn’t ...

Early seizure onset in DEPDC5-related epilepsy is linked to more severe disease, including drug resistance, intellectual disability, and brain lesions.

Researchers from the Center for Precision Psychiatry at the University of Oslo and Oslo University Hospital have discovered ...

Rice University bioengineers have demonstrated a nonsurgical way to quiet a seizure-relevant brain circuit in an animal model. The team used low-intensity focused ultrasound to briefly open the ...